-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-section-5-attach-5.pdf
February 02, 2012 - was identified in the previous guide-
line, the most common stimulant ad-
verse effects are appetite loss
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-131-fullreport.pdf
April 05, 2017 - include
direct costs of medical care and indirect costs, such as school absenteeism and parental work loss
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/implementation-guide-making-informed-consent-informed-choice.pdf
January 01, 2017 - ■ The principal risk of this survey is a small risk of loss of confidentiality.
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-088-fullreport.pdf
January 05, 2017 - Accurate ADHD Diagnosis
Accurate ADHD Diagnosis
Section 1. Basic Measure Information
1.A. Measure Name
Accurate ADHD Diagnosis
1.B. Measure Number
0088
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it measures to
a broad audience.
Percentage of patien…
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/helpful-resources/analysis/2020-instructions-for-analyzing-data.pdf
January 01, 2020 - A disadvantage of this option is a possible loss of statistical
precision if an item with few responses
-
www.cahps.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2019qdr-datasources.pdf
December 01, 2020 - system that aims to identify rates of specific adverse
events, or unintended patient harm, injury, or loss